IBIO

Value Q4, 24Q1, 25Q2, 25 TTM Total revenue 200 K100 K0 300 K Gross profit 200 K100 K0 300 K Operating expenses 5.4 M6.05 M9.45 M 25.77 M Selling/general/admin expenses 2.17 M2.5 M5.17 M 12.81 M Research & development 3.22 M3.55 M4.28 M 12.96 M Operating income -5.2 M-5.95 M-9.45 M -25.47 M Non-Operating Income, Total 35 K231 K452 K 736 K Interest expense, net of interest capitalized 44 K36 K41 K 175 K Non-Operating Income, excl. Interest Expenses -9 000195 K411 K 561 K Unusual income/expense ——— — Pretax income -5.21 M-5.76 M-9.03 M -24.91 M Equity in earnings ——— — Taxes 000 0 Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -631 K-5.72 M-8.99 M -19.67 M Discontinued operations -4.53 M—— — Net income -5.16 M-5.72 M-8.99 M -24.74 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -5.16 M-5.67 M-8.99 M -24.69 M Basic earnings per share (Basic EPS) -0.32-0.11-0.09 -1.01 Diluted earnings per share (Diluted EPS) -0.32-0.11-0.09 -1.01 Average basic shares outstanding 10.5 M52.98 M99.13 M 172.47 M Diluted shares outstanding 10.5 M52.98 M99.13 M 172.47 M EBITDA -4.99 M3.24 M-9.3 M -15.74 M EBIT -5.2 M-5.95 M-9.45 M -25.47 M Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 209 K9.19 M146 K 9.73 M